J. Michael Pearson

2014 - Valeant Pharmaceuticals International

In 2014, J. Michael Pearson earned a total compensation of $10.4M as Chief Executive Officer at Valeant Pharmaceuticals International, a 48% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$8,000,000
Salary$2,007,693
Other$368,235
Total$10,375,928

Pearson received $8M in non-equity incentive plan, accounting for 77% of the total pay in 2014.

Pearson also received $2M in salary and $368.2K in other compensation.

Rankings

In 2014, J. Michael Pearson's compensation ranked 483rd out of 13,032 executives tracked by ExecPay. In other words, Pearson earned more than 96.3% of executives.

ClassificationRankingPercentile
All
483
out of 13,032
96th
Division
Manufacturing
165
out of 4,967
97th
Major group
Chemicals And Allied Products
53
out of 1,690
97th
Industry group
Drugs
43
out of 1,369
97th
Industry
Pharmaceutical Preparations
40
out of 1,042
96th
Source: SEC filing on April 29, 2016.

Pearson's colleagues

We found six more compensation records of executives who worked with J. Michael Pearson at Valeant Pharmaceuticals International in 2014.

2014

Ari Kellen

Valeant Pharmaceuticals International

Group Chairman

2014

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

2014

Robert Chai-Onn

Valeant Pharmaceuticals International

Chief Legal Officer

2014

Pavel Mirovsky

Valeant Pharmaceuticals International

President and General Manager, Europe

2014

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2014

Brian Stolz

Valeant Pharmaceuticals International

Senior Vice President and General Manager

You may also like